The pursuit of outperformance leads many investors to carefully choose individual stocks. Picking the right ones can be a game-changer for growing your wealth.
The closing price of Calumet Inc (NASDAQ: CLMT) was $12.23 for the day, down -3.47% from the previous closing price of $12.67. In other words, the price has decreased by -$3.47 from its previous closing price. On the day, 0.72 million shares were traded. CLMT stock price reached its highest trading level at $12.975 during the session, while it also had its lowest trading level at $12.22.
Ratios:
Our analysis of CLMT’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 0.40 and its Current Ratio is at 0.89.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, UBS on March 17, 2025, Upgraded its rating to Neutral and sets its target price to $12 from $15 previously.
On March 04, 2025, TD Cowen Downgraded its rating to Hold which previously was Buy and also lowered its target price recommendation from $26 to $16.
UBS Downgraded its Neutral to Sell on February 04, 2025, whereas the target price for the stock was revised from $20.50 to $15.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Mar 24 ’25 when Mawer Stephen P bought 3,655 shares for $12.77 per share.
Mawer Stephen P sold 3,655 shares of CLMT for $46,199 on Mar 06 ’25. The Director now owns 196,898 shares after completing the transaction at $12.64 per share. On Mar 06 ’25, another insider, Mawer Stephen P, who serves as the Officer of the company, bought 3,655 shares for $12.53 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CLMT now has a Market Capitalization of 1054312832 and an Enterprise Value of 3635912960. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.25. Its current Enterprise Value per Revenue stands at 0.868 whereas that against EBITDA is 16.081.
Stock Price History:
The Beta on a monthly basis for CLMT is 1.42, which has changed by -0.14951319 over the last 52 weeks, in comparison to a change of 0.10063088 over the same period for the S&P500. Over the past 52 weeks, CLMT has reached a high of $25.29, while it has fallen to a 52-week low of $9.97. The 50-Day Moving Average of the stock is -19.39%, while the 200-Day Moving Average is calculated to be -30.53%.
Shares Statistics:
CLMT traded an average of 1.37M shares per day over the past three months and 1206300 shares per day over the past ten days. A total of 85.95M shares are outstanding, with a floating share count of 68.46M. Insiders hold about 20.58% of the company’s shares, while institutions hold 42.27% stake in the company. Shares short for CLMT as of 1741910400 were 9771059 with a Short Ratio of 7.06, compared to 1739491200 on 8574553. Therefore, it implies a Short% of Shares Outstanding of 9771059 and a Short% of Float of 13.600000000000001.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0The stock’s 5-year Average Dividend Yield is 14.83.
Earnings Estimates
The firm’s stock currently is rated by 1.0 analysts. The consensus estimate for the next quarter is -$0.08, with high estimates of -$0.08 and low estimates of -$0.08.
Analysts are recommending an EPS of between -$0.47 and -$0.47 for the fiscal current year, implying an average EPS of -$0.47. EPS for the following year is $0.26, with 1.0 analysts recommending between $0.26 and $0.26.
Revenue Estimates
It is expected that $90B in revenue will be generated in the current quarter, according to 5 analysts. It ranges from a high estimate of $1.05B to a low estimate of $733.29M. As of the current estimate, Calumet Inc’s year-ago sales were $1.01BFor the next quarter, 5 analysts are estimating revenue of $952.38M. There is a high estimate of $1.06B for the next quarter, whereas the lowest estimate is $842.4M.
A total of 5 analysts have provided revenue estimates for CLMT’s current fiscal year. The highest revenue estimate was $4.31B, while the lowest revenue estimate was $3.23B, resulting in an average revenue estimate of $3.8B. In the same quarter a year ago, actual revenue was $4.19BBased on 5 analysts’ estimates, the company’s revenue will be $3.92B in the next fiscal year. The high estimate is $4.61B and the low estimate is $3.39B.
